Hirsch MS - Search Results

1

Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidine.

Johnson VA, Barlow MA, Chou TC, Fisher RA, Walker BD, Hirsch MS, Schooley RT. Johnson VA, et al. Among authors: hirsch ms. J Infect Dis. 1989 May;159(5):837-44. doi: 10.1093/infdis/159.5.837. J Infect Dis. 1989. PMID: 2785146

2

Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine.

Johnson VA, Walker BD, Barlow MA, Paradis TJ, Chou TC, Hirsch MS. Johnson VA, et al. Among authors: hirsch ms. Antimicrob Agents Chemother. 1989 Jan;33(1):53-7. doi: 10.1128/AAC.33.1.53. Antimicrob Agents Chemother. 1989. PMID: 2653214 Free PMC article.

3

HIV infection is blocked in vitro by recombinant soluble CD4.

Fisher RA, Bertonis JM, Meier W, Johnson VA, Costopoulos DS, Liu T, Tizard R, Walker BD, Hirsch MS, Schooley RT, et al. Fisher RA, et al. Among authors: hirsch ms. Nature. 1988 Jan 7;331(6151):76-8. doi: 10.1038/331076a0. Nature. 1988. PMID: 2829022

4

Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1.

Vogt MW, Durno AG, Chou TC, Coleman LA, Paradis TJ, Schooley RT, Kaplan JC, Hirsch MS. Vogt MW, et al. Among authors: hirsch ms. J Infect Dis. 1988 Aug;158(2):378-85. doi: 10.1093/infdis/158.2.378. J Infect Dis. 1988. PMID: 2841378

5

Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus.

Blumberg RS, Paradis T, Hartshorn KL, Vogt M, Ho DD, Hirsch MS, Leban J, Sato VL, Schooley RT. Blumberg RS, et al. Among authors: hirsch ms. J Infect Dis. 1987 Dec;156(6):878-84. doi: 10.1093/infdis/156.6.878. J Infect Dis. 1987. PMID: 3479500

6

Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro.

Merrill DP, Moonis M, Chou TC, Hirsch MS. Merrill DP, et al. Among authors: hirsch ms. J Infect Dis. 1996 Feb;173(2):355-64. doi: 10.1093/infdis/173.2.355. J Infect Dis. 1996. PMID: 8568296

7

Antagonism between human immunodeficiency virus type 1 protease inhibitors indinavir and saquinavir in vitro.

Merrill DP, Manion DJ, Chou TC, Hirsch MS. Merrill DP, et al. Among authors: hirsch ms. J Infect Dis. 1997 Jul;176(1):265-8. doi: 10.1086/517263. J Infect Dis. 1997. PMID: 9207379

8

Improved CD4 lymphocyte outgrowth in response to effective antiretroviral therapy.

Merrill DP, Martinez-Picado J, Tremblay C, Sax PE, Boswell SL, Wong JT, D'Aquila RT, Walker BD, Hirsch MS. Merrill DP, et al. Among authors: hirsch ms. J Infect Dis. 1999 Feb;179(2):345-51. doi: 10.1086/314591. J Infect Dis. 1999. PMID: 9878017 Clinical Trial.

9

Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro.

Eron JJ Jr, Johnson VA, Merrill DP, Chou TC, Hirsch MS. Eron JJ Jr, et al. Among authors: hirsch ms. Antimicrob Agents Chemother. 1992 Jul;36(7):1559-62. doi: 10.1128/AAC.36.7.1559. Antimicrob Agents Chemother. 1992. PMID: 1324648 Free PMC article.

10

Human immunodeficiency virus type 1 (HIV-1) inhibitory interactions between protease inhibitor Ro 31-8959 and zidovudine, 2',3'-dideoxycytidine, or recombinant interferon-alpha A against zidovudine-sensitive or -resistant HIV-1 in vitro.

Johnson VA, Merrill DP, Chou TC, Hirsch MS. Johnson VA, et al. Among authors: hirsch ms. J Infect Dis. 1992 Nov;166(5):1143-6. doi: 10.1093/infdis/166.5.1143. J Infect Dis. 1992. PMID: 1328402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

502 results

Search Page

Filters